Fierce Biotech April 18, 2024
Conor Hale

Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year.

The successful cash bid of about $392.6 million will lift NanoString out of bankruptcy proceedings and aims to ensure customers’ access to the company’s multi-omic products through Bruker’s life science instrument catalog.

“The sale to Bruker will also bring about a swift conclusion of our restructuring process,” NanoString President and CEO Brad Gray said in a statement. “Our loyal customers, suppliers and employees have stood with us through this dynamic period, and we are grateful for their dedication to the future of our technology and our mission to map the universe...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
How digital health companies are capitalizing on the GLP-1 boom
Journalists Zero In on Bird Flu and Weight Loss Drugs
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials
Chasing the alchemy of trial diversity with a mix of culture change and practical mechanics
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds

Share This Article